These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24607053)

  • 1. Use of abatacept in eosinophilic asthma.
    Abdelshaeed R; Griffiths GB; Neighbour H
    J Allergy Clin Immunol Pract; 2014; 2(2):220-1. PubMed ID: 24607053
    [No Abstract]   [Full Text] [Related]  

  • 2. Abatacept use after failure of multiple biologic agents in patients with severe rheumatoid arthritis.
    Hazlewood GS; Barnabe C; Barr SG; Martin L
    J Clin Rheumatol; 2012 Dec; 18(8):416-8. PubMed ID: 23188208
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis complicated with severe liver injury during treatment with abatacept.
    Iwanaga N; Origuchi T; Terada K; Ueki Y; Kamo Y; Kinoshita N; Yonemitsu N; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Kawakami A
    Mod Rheumatol; 2014 Sep; 24(5):874-6. PubMed ID: 24611764
    [No Abstract]   [Full Text] [Related]  

  • 4. Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection.
    Mahajan TD; Hooker R; Maher L; Brown G; Reimold A
    J Clin Rheumatol; 2010 Oct; 16(7):332-4. PubMed ID: 20859223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abatacept management during the perioperative period in patients with rheumatoid arthritis: report on eight orthopaedic procedures.
    Nishida K; Nasu Y; Hashizume K; Nakahara R; Ozawa M; Harada R; Machida T; Ozaki T
    Mod Rheumatol; 2014 May; 24(3):544-5. PubMed ID: 24506697
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte-associated antigen 4 Ig-induced asthma in the treatment of rheumatoid arthritis.
    Bao J; Li T; Zhao J; Zhang CY
    J Rheumatol; 2012 Sep; 39(9):1903. PubMed ID: 22942310
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab and abatacept for rheumatoid arthritis.
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
    Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
    [No Abstract]   [Full Text] [Related]  

  • 9. Abatacept helps people with severe RA.
    Health News; 2006 Oct; 12(10):2. PubMed ID: 17165175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Abatacept in the treatment of active rheumatoid arthritis].
    Nielsen H; Hansen A
    Ugeskr Laeger; 2009 Jan; 171(4):214-7. PubMed ID: 19174034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NICE and new drugs for rheumatoid arthritis.
    Lancet; 2008 May; 371(9623):1477. PubMed ID: 18456081
    [No Abstract]   [Full Text] [Related]  

  • 12. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
    Scheinfeld N
    J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.
    Shimizu Y; Kurosawa M; Sutoh Y; Sutoh E
    J Investig Allergol Clin Immunol; 2020 Apr; 30(2):154-155. PubMed ID: 31778113
    [No Abstract]   [Full Text] [Related]  

  • 14. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis.
    Barr C
    J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of steroid therapy on inflammatory cell subtypes in asthma.
    Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
    Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abatacept in rheumatoid arthritis: a new branch on the "biologics" tree.
    Boers M
    Ann Intern Med; 2006 Jun; 144(12):933-5. PubMed ID: 16785481
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept.
    Gómez-García L; Ramírez-Assad C; Vargas A; Massó F; Sánchez-Muñoz F; Márquez-Velasco R; Amezcua-Guerra LM; Bojalil R
    Int J Rheum Dis; 2013 Aug; 16(4):469-71. PubMed ID: 23992270
    [No Abstract]   [Full Text] [Related]  

  • 18. Abatacept in the treatment of rheumatoid arthritis.
    Todd DJ; Costenbader KH; Weinblatt ME
    Int J Clin Pract; 2007 Mar; 61(3):494-500. PubMed ID: 17313619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic alleles in exon 1 of the CTLA4 gene do not predict the response to abatacept.
    Talotta R; Bagnato GL; Atzeni F; Ditto MC; Bitto A; Squadrito F; Lo Gullo A; Sarzi-Puttini P; Bagnato GF
    Clin Exp Rheumatol; 2013; 31(5):813. PubMed ID: 23739065
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.
    Weinblatt M; Combe B; Covucci A; Aranda R; Becker JC; Keystone E
    Arthritis Rheum; 2006 Sep; 54(9):2807-16. PubMed ID: 16947384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.